Buttorff Leslie's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed Mar 1, 2023
- Accession no.
- 0001493152-23-006398
- Filed
- Mar 1, 2023, 4:21 PM ET
- Trade date
- Feb 26-27, 2023
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $725. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buttorff LeslieCIK 0001866792 | Director, Officer (CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $0.19 | +$190 | 706,949 | Direct | |
| Feb 27, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $0.1725 | +$345 | 708,949 | Direct | |
| Feb 27, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $0.19 | +$190 | 709,949 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.